Meta-analysis of the association of the Rs2234693 and Rs9340799 polymorphisms of estrogen receptor alpha gene with coronary heart disease risk in Chinese Han population

International Journal of Medical Sciences

Volumn 10, Issue 4, 2013, Pages 457-466

  Wei, Chuan Dong ^a,b   Zheng, Hong Yun ^a   Wu, Wei ^a   Dai, Wen ^a   Tong, Yong Qing ^a   Wang, Ming ^a   Li, Yan ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF YOUJIANG MEDICAL UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

Coronary heart disease; Estrogen receptor alpha gene; Meta analysis; Single nucleotide polymorphisms

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN RECEPTOR ALPHA GENE; FEMALE; GENE; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS;

CORONARY HEART DISEASE; ESTROGEN RECEPTOR ALPHA GENE; META-ANALYSIS.; SINGLE NUCLEOTIDE POLYMORPHISMS;

CASE-CONTROL STUDIES; CORONARY DISEASE; ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84874782434     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5234     Document Type: Article

References (44)

1. Negi S, Anand A. Atherosclerotic coronary heart disease-epidemiology, classification and management. Cardiovascular & hematological disorders drug targets. 2010; 10: 257-21.
2. Mi X, Eskridge KM, George V, et al. Structural equation modeling of gene-environment interactions in coronary heart disease. Annals of human genetics. 2011; 75: 255-25.
3. Isles CG, Hole DJ, Hawthorne VM, et al. Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet. 1992; 339: 702-70
4. Gurevitz O, Jonas M, Boyko V, et al. Clinical profile and long-term prognosis of women < or = 50 years of age referred for coronary angiography for evaluation of chest pain. The American journal of cardiology. 2000; 85: 806-80
5. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Preventive medicine. 1991; 20: 47-63.
6. Konukoglu D, Serin O, Ercan M. The relationship between plasma viscosity and cholesterol in postmenopausal women on hormone replacement therapy. Clinical hemorheology and microcirculation. 2000; 22: 223-22
7. Burns KA, Korach KS. Estrogen receptors and human disease: an update. Archives of toxicology. 2012; 86: 1491-1504.
8. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995; 83: 835-839.
9. Hewitt SC, O'Brien JE, Jameson JL, et al. Selective disruption of ER{alpha} DNA-binding activity alters uterine responsiveness to estradiol. Mol Endocrinol. 2009; 23: 2111-2116.
10. Burns KA, Li Y, Arao Y, et al. Selective mutations in estrogen receptor alpha D-domain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms. The Journal of biological chemistry. 2011; 286: 12640-12649.
11. Losordo DW, Kearney M, Kim EA, et al. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 1994; 89: 1501-1510.
12. Pare G, Krust A, Karas RH, et al. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circulation research. 2002; 90: 1087-1092.
13. Booth EA, Obeid NR, Lucchesi BR. Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury. American journal of physiology Heart and circulatory physiology. 2005; 289: H2039-H2047.
14. Zhai P, Eurell TE, Cooke PS, et al. Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice. American journal of physiology Heart and circulatory physiology. 2000; 278: H1640-H1647.
15. Herrington DM, Howard TD, Brosnihan KB, et al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation. 2002; 105: 1879-1882.
16. Nordstrom P, Glader CA, Dahlen G, et al. Oestrogen receptor alpha gene polymorphism is related to aortic valve sclerosis in postmenopausal women. Journal of internal medicine. 2003; 254: 140-146.
17. Mansur Ade P, Nogueira CC, Strunz CM, et al. Genetic polymorphisms of estrogen receptors in patients with premature coronary artery disease. Archives of medical research. 2005; 36: 511-517.
18. Boroumand M, Ghaedi M, Mohammadtaghvaei N, et al. Association of estrogen receptor alpha gene polymorphism with the presence of coronary artery disease documented by coronary angiography. Clinical biochemistry. 2009; 42: 835-839.
19. Xu H, Hou X, Wang N, et al. Gender-specific effect of estrogen receptor-1 gene polymorphisms in coronary artery disease and its angiographic severity in Chinese population. Clinica chimica acta, international journal of clinical chemistry. 2008; 395: 130-133.
20. Lawlor DA, Timpson N, Ebrahim S, et al. The association of oestrogen receptor alpha-haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study. European heart journal. 2006; 27: 1597-1604.
21. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA: the journal of the American Medical Association. 2000; 283: 2008-2012.
22. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994; 90: 583-612.
23. Thakkinstian A, McElduff P, D'Este C, et al. A method for meta-analysis of molecular association studies. Statistics in medicine. 2005; 24: 1291-1306.
24. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003; 327: 557-560.
25. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in medicine. 2002; 21: 1539-1558.
26. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Annals of internal medicine. 1997; 127: 820-826.
27. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50: 1088-1101.
28. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315: 629-634.
29. Zheng H. Relationship between estrogen receptor gene polymorphism and coronary heart disease. PhD thesis, The first military medical university. 2001.
30. Guo ZG, Zheng H, Wu SZ, et al. Relatioonship between estrogen receptor gene polymorphism and coronary heart disease. Chinese Journal of Geriatric Heart Brain and Vessel Diseases. 2002; 4: 374-377.
31. Huang XZ, Zhang PA, Li Y, et al. Association of estrogen receptor gene polymorphisms with coronary heart disease. Chinese Journal of Cardiology. 2002; 30: 78-81.
32. Zheng HM. The study about the association between the polymorphisms of the estrogen receptor and coronary artery disease or the lipoprotein metabolism in women. PhD thesis, Hebei Medical University. 2002.
33. Cheng AJ, Fu NK, Xu J, et al. A study of the correlation between estrogen receptor gene polymorphism and coronary heart disease as well as serum lipid levels in postmenopausal women. Hebei Medical Journal (China). 2006; 28: 568-570.
34. Li LH, Zhao FM, Li GQ, et al. Association between estrogen receptor alpha gene variation and risk of cardiovascular disease. Molecular Cardiology of China. 2006; 6: 90-94.
35. Tang ZZ, Li XP, Yang JH, et al. Relationship of estrogen receptor α gene polymorphism and risk of cardiovascular disease. Military Medical Journal of South China. 2008; 22: 35-37
36. Jin LZ, Chen XC, Ma YD, et al. Association of estrogen receptor α gene Pvu II and Xba I polymorphisms with coronary artery disease. Chinese Journal of Biomedical Engineering. 2010; 16: 136-139.
37. Shen C, Chen J, Fan S, et al. Association between the polymorphism of estrogen receptor alpha and coronary artery disease in a Chinese population. European journal of internal medicine. 2012; 23: 175-178.
38. Hodgin JB, Krege JH, Reddick RL, et al. Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice. The Journal of clinical investigation. 2001; 107: 333-340.
39. Shearman AM, Cupples LA, Demissie S, et al. Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA: the journal of the American Medical Association. 2003; 290: 2263-2270.
40. Lehtimaki T, Kunnas TA, Mattila KM, et al. Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study. J Mol Med (Berl). 2002; 80: 176-180.
41. Schuit SC, Oei HH, Witteman JC, et al. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. JAMA: the journal of the American Medical Association. 2004; 291: 2969-2977.
42. Koch W, Hoppmann P, Pfeufer A, et al. No replication of association between estrogen receptor alpha gene polymorphisms and susceptibility to myocardial infarction in a large sample of patients of European descent. Circulation. 2005; 112: 2138-2142.
43. Kjaergaard AD, Ellervik C, Tybjaerg-Hansen A, et al. Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta- analysis. Circulation. 2007; 115: 861-871.
44. Lluis-Ganella C, Lucas G, Subirana I, et al. Qualitative assessment of previous evidence and an updated meta-analysis confirms lack of association between the ESR1 rs2234693 (PvuII) variant and coronary heart disease in men and women. Atherosclerosis. 2009; 207: 480-486.